Hydrogen Protects Liver from Cancer Drug Damage in Mice

Authors
Journal
International Journal of Molecular Sciences
Year
DOI
10.3390/ijms27062774
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Drug-Induced Liver Injury
Body System
Hepatic

TL;DR

Hydrogen reduced doxorubicin-induced liver injury by lowering oxidative stress, inflammation, and fibrosis via activation of the Nrf2/HO-1 pathway.

Key Finding

Hydrogen treatment significantly reduced doxorubicin-induced liver damage in mice by activating the Nrf2/HO-1 cellular pathway, which decreased oxidative stress and inflammation.

Summary

Researchers tested whether hydrogen could protect mouse livers from damage caused by doxorubicin, a chemotherapy drug known to harm the liver. They found that hydrogen treatment reduced liver damage, decreased cell death, lowered inflammation, and reduced harmful molecules called free radicals in the liver tissue. The protective effect appeared to work by activating a specific cellular pathway (Nrf2/HO-1) that helps cells defend themselves against damage.

Practical Takeaway

This is an early-stage animal study suggesting hydrogen may have protective effects against chemotherapy-related liver damage. However, because this research was only conducted in mice, not humans, and the study details (duration, sample size) were not reported, it's too early to draw conclusions about whether hydrogen water would protect human livers during cancer treatment. Human clinical trials would be needed to determine if these findings apply to people.

Abstract

Drug-induced liver injury constitutes a major concern within the spectrum of drug-related pathologies. The precise mechanisms underlying doxorubicin (DOX)-induced liver injury remain inadequately elucidated. Hydrogen is known for its selective antioxidant properties and favorable safety profile; however, its protective effects against DOX-induced liver injury have not been fully clarified. In this study, a model of DOX-induced liver injury was established to evaluate hepatic function and pathological alteration, thereby assessing the therapeutic efficacy of hydrogen. Further investigations were conducted to quantify oxidative stress and inflammatory markers to elucidate the potential mechanisms involved. Hydrogen treatment significantly mitigated DOX-induced liver damage and inhibited hepatocyte fibrosis. Hydrogen was found to suppress apoptosis, reduce oxidative stress levels, and ameliorate inflammatory responses in the liver tissue of DOX mice. The protective effect was predominantly facilitated by the modulation of the Nrf2/HO-1 pathway. Importantly, the hepatoprotective effect of hydrogen was negated following the administration of an Nrf2 inhibitor in HepG2 cells. These results suggest that hydrogen may mitigate DOX-induced liver injury by activating the Nrf2/HO-1 signaling pathway, consequently diminishing oxidative stress and inflammatory responses.